Submit a Release
Home
All
ESG
Health
Technology
Finance
Contributors
Sub Menu
Submit a Release
main-search-pop
Main menu
Norgine completes acquisition of Theravia
Contributed by:
PR Newswire
Images
Tags
Norgine-Theravia
More Like This
Norgine strengthens rare disease portfolio with acquisition of Theravia
Norgine Announces Appointment of New CEO Janneke van der Kamp
Norgine enhances hepatology and specialty portfolio through exclusive in-licensing agreement with Vir Biotechnology
X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor - licenced to Norgine for commercialisation in Europe.
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
Orphalan announces acquisition of Orphelia Pharma
Navamedic ASA: Closing of the transaction to acquire the business of dne pharma
Navamedic ASA expands into addiction treatment through the acquisition of the business of dne pharma and announces a partially underwritten rights issue
